News >

Precision Medicine Propels Research Efforts in Breast Cancer

Caroline Seymour
Published: Wednesday, Dec 04, 2019

Mark E. Robson, MD,  chief of Breast Medicine Service, Memorial Sloan Kettering Cancer Center

Mark E. Robson, MD

Genomics, targeted agents, and immunotherapy are core components of the precision medicine focus that is driving research efforts in breast cancer, explained Mark E. Robson, MD.  


“The big areas that we’re focusing on are advances with endocrine therapy, particularly with CDK4/6 inhibition, and, now also with PI3K inhibition,” said Robson, chief of Breast Medicine Service, Memorial Sloan Kettering Cancer Center. “The second big area is immunotherapy, and that’s not just in breast cancer; that approach is being examined across oncology. Within the past year, however, we’ve broken a glass ceiling in breast cancer.” 

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication